小分子注射剤のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Small Molecule Injectable Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B15613 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療装置

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

小分子注射剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の小分子注射剤の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界の小分子注射剤の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 小分子注射剤市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・静脈内（IV）、筋肉内（IM）、皮下（SC） 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界の小分子注射剤市場の主要な市場プレーヤーは以下のとおりです。 ・Aurobindo Pharma Limited、Teva Pharmaceutical Industries Ltd.、Merck & Co. Inc.、AstraZeneca Plc、Pfizer Inc.、Sun Pharmaceutical Industries Ltd.、Novartis AG、Baxter International、Fresenius Kabi、Cipla Ltd、Mylan N.V.、Sanofi S.A、Dr. Reddy’s Laboratories Ltd 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、小分子注射剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な小分子注射剤メーカーの企業概要、2019年～2021年までの小分子注射剤の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な小分子注射剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別小分子注射剤の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までの小分子注射剤の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域での小分子注射剤市場予測を収録しています。 ・第12、13、14章では、小分子注射剤の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Aurobindo Pharma Limited、Teva Pharmaceutical Industries Ltd.、Merck & Co. Inc.、AstraZeneca Plc、Pfizer Inc.、Sun Pharmaceutical Industries Ltd.、Novartis AG、Baxter International、Fresenius Kabi、Cipla Ltd、Mylan N.V.、Sanofi S.A、Dr. Reddy’s Laboratories Ltd ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：静脈内（IV）、筋肉内（IM）、皮下（SC） ・用途別分析2016年-2026年：病院、クリニック、その他 ・小分子注射剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・小分子注射剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・小分子注射剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・小分子注射剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・小分子注射剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Small Molecule Injectable market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Small Molecule Injectable size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Small Molecule Injectable market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Small Molecule Injectable market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Intravenous (IV)
Intramuscular (IM)
Subcutaneous (SC)

Market segment by Application can be divided into
Hospital
Clinic
Other

The key market players for global Small Molecule Injectable market are listed below:
Aurobindo Pharma Limited
Teva Pharmaceutical Industries Ltd.
Merck & Co. Inc.
AstraZeneca Plc
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Novartis AG
Baxter International
Fresenius Kabi
Cipla Ltd
Mylan N.V.
Sanofi S.A
Dr. Reddy’s Laboratories Ltd

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Small Molecule Injectable product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Small Molecule Injectable, with price, sales, revenue and global market share of Small Molecule Injectable from 2019 to 2021.
Chapter 3, the Small Molecule Injectable competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Small Molecule Injectable breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Small Molecule Injectable market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Small Molecule Injectable sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Small Molecule Injectable Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Small Molecule Injectable Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Intravenous (IV)
1.2.3 Intramuscular (IM)
1.2.4 Subcutaneous (SC)
1.3 Market Analysis by Application
1.3.1 Overview: Global Small Molecule Injectable Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Small Molecule Injectable Market Size & Forecast
1.4.1 Global Small Molecule Injectable Sales in Value (2016-2026))
1.4.2 Global Small Molecule Injectable Sales in Volume (2016-2026)
1.4.3 Global Small Molecule Injectable Price by Type (2016-2026) & (US$/Unit)
1.5 Global Small Molecule Injectable Production Capacity Analysis
1.5.1 Global Small Molecule Injectable Total Production Capacity (2016-2026)
1.5.2 Global Small Molecule Injectable Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Small Molecule Injectable Market Drivers
1.6.2 Small Molecule Injectable Market Restraints
1.6.3 Small Molecule Injectable Trends Analysis
2 Manufacturers Profiles
2.1 Aurobindo Pharma Limited
2.1.1 Aurobindo Pharma Limited Details
2.1.2 Aurobindo Pharma Limited Major Business
2.1.3 Aurobindo Pharma Limited Small Molecule Injectable Product and Services
2.1.4 Aurobindo Pharma Limited Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Teva Pharmaceutical Industries Ltd.
2.2.1 Teva Pharmaceutical Industries Ltd. Details
2.2.2 Teva Pharmaceutical Industries Ltd. Major Business
2.2.3 Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Product and Services
2.2.4 Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Merck & Co. Inc.
2.3.1 Merck & Co. Inc. Details
2.3.2 Merck & Co. Inc. Major Business
2.3.3 Merck & Co. Inc. Small Molecule Injectable Product and Services
2.3.4 Merck & Co. Inc. Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 AstraZeneca Plc
2.4.1 AstraZeneca Plc Details
2.4.2 AstraZeneca Plc Major Business
2.4.3 AstraZeneca Plc Small Molecule Injectable Product and Services
2.4.4 AstraZeneca Plc Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Pfizer Inc.
2.5.1 Pfizer Inc. Details
2.5.2 Pfizer Inc. Major Business
2.5.3 Pfizer Inc. Small Molecule Injectable Product and Services
2.5.4 Pfizer Inc. Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Sun Pharmaceutical Industries Ltd.
2.6.1 Sun Pharmaceutical Industries Ltd. Details
2.6.2 Sun Pharmaceutical Industries Ltd. Major Business
2.6.3 Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Product and Services
2.6.4 Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Novartis AG
2.7.1 Novartis AG Details
2.7.2 Novartis AG Major Business
2.7.3 Novartis AG Small Molecule Injectable Product and Services
2.7.4 Novartis AG Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Baxter International
2.8.1 Baxter International Details
2.8.2 Baxter International Major Business
2.8.3 Baxter International Small Molecule Injectable Product and Services
2.8.4 Baxter International Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Fresenius Kabi
2.9.1 Fresenius Kabi Details
2.9.2 Fresenius Kabi Major Business
2.9.3 Fresenius Kabi Small Molecule Injectable Product and Services
2.9.4 Fresenius Kabi Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Cipla Ltd
2.10.1 Cipla Ltd Details
2.10.2 Cipla Ltd Major Business
2.10.3 Cipla Ltd Small Molecule Injectable Product and Services
2.10.4 Cipla Ltd Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Mylan N.V.
2.11.1 Mylan N.V. Details
2.11.2 Mylan N.V. Major Business
2.11.3 Mylan N.V. Small Molecule Injectable Product and Services
2.11.4 Mylan N.V. Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Sanofi S.A
2.12.1 Sanofi S.A Details
2.12.2 Sanofi S.A Major Business
2.12.3 Sanofi S.A Small Molecule Injectable Product and Services
2.12.4 Sanofi S.A Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Dr. Reddy’s Laboratories Ltd
2.13.1 Dr. Reddy’s Laboratories Ltd Details
2.13.2 Dr. Reddy’s Laboratories Ltd Major Business
2.13.3 Dr. Reddy’s Laboratories Ltd Small Molecule Injectable Product and Services
2.13.4 Dr. Reddy’s Laboratories Ltd Small Molecule Injectable Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Small Molecule Injectable Sales by Manufacturer
3.1 Global Small Molecule Injectable Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Small Molecule Injectable Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Small Molecule Injectable
3.4 Market Concentration Rate
3.4.1 Top 3 Small Molecule Injectable Manufacturer Market Share
3.4.2 Top 6 Small Molecule Injectable Manufacturer Market Share
3.5 Global Small Molecule Injectable Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Small Molecule Injectable Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Small Molecule Injectable Market Size by Region
4.1.1 Global Small Molecule Injectable Sales in Volume by Region (2016-2026)
4.1.2 Global Small Molecule Injectable Revenue by Region (2016-2026)
4.2 North America Small Molecule Injectable Revenue (2016-2026)
4.3 Europe Small Molecule Injectable Revenue (2016-2026)
4.4 Asia-Pacific Small Molecule Injectable Revenue (2016-2026)
4.5 South America Small Molecule Injectable Revenue (2016-2026)
4.6 Middle East and Africa Small Molecule Injectable Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Small Molecule Injectable Sales in Volume by Type (2016-2026)
5.2 Global Small Molecule Injectable Revenue by Type (2016-2026)
5.3 Global Small Molecule Injectable Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Small Molecule Injectable Sales in Volume by Application (2016-2026)
6.2 Global Small Molecule Injectable Revenue by Application (2016-2026)
6.3 Global Small Molecule Injectable Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Small Molecule Injectable Sales by Type (2016-2026)
7.2 North America Small Molecule Injectable Sales by Application (2016-2026)
7.3 North America Small Molecule Injectable Market Size by Country
7.3.1 North America Small Molecule Injectable Sales in Volume by Country (2016-2026)
7.3.2 North America Small Molecule Injectable Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Small Molecule Injectable Sales by Type (2016-2026)
8.2 Europe Small Molecule Injectable Sales by Application (2016-2026)
8.3 Europe Small Molecule Injectable Market Size by Country
8.3.1 Europe Small Molecule Injectable Sales in Volume by Country (2016-2026)
8.3.2 Europe Small Molecule Injectable Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Small Molecule Injectable Sales by Type (2016-2026)
9.2 Asia-Pacific Small Molecule Injectable Sales by Application (2016-2026)
9.3 Asia-Pacific Small Molecule Injectable Market Size by Region
9.3.1 Asia-Pacific Small Molecule Injectable Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Small Molecule Injectable Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Small Molecule Injectable Sales by Type (2016-2026)
10.2 South America Small Molecule Injectable Sales by Application (2016-2026)
10.3 South America Small Molecule Injectable Market Size by Country
10.3.1 South America Small Molecule Injectable Sales in Volume by Country (2016-2026)
10.3.2 South America Small Molecule Injectable Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Small Molecule Injectable Sales by Type (2016-2026)
11.2 Middle East & Africa Small Molecule Injectable Sales by Application (2016-2026)
11.3 Middle East & Africa Small Molecule Injectable Market Size by Country
11.3.1 Middle East & Africa Small Molecule Injectable Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Small Molecule Injectable Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Small Molecule Injectable Typical Distributors
12.3 Small Molecule Injectable Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Small Molecule Injectable Revenue by Type, (USD Million), 2021-2026
Table 2. Global Small Molecule Injectable Revenue by Application, (USD Million), 2021-2026
Table 3. Aurobindo Pharma Limited Basic Information, Manufacturing Base and Competitors
Table 4. Aurobindo Pharma Limited Major Business
Table 5. Aurobindo Pharma Limited Small Molecule Injectable Product and Services
Table 6. Aurobindo Pharma Limited Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 8. Teva Pharmaceutical Industries Ltd. Major Business
Table 9. Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Product and Services
Table 10. Teva Pharmaceutical Industries Ltd. Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 12. Merck & Co. Inc. Major Business
Table 13. Merck & Co. Inc. Small Molecule Injectable Product and Services
Table 14. Merck & Co. Inc. Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 16. AstraZeneca Plc Major Business
Table 17. AstraZeneca Plc Small Molecule Injectable Product and Services
Table 18. AstraZeneca Plc Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Inc. Major Business
Table 21. Pfizer Inc. Small Molecule Injectable Product and Services
Table 22. Pfizer Inc. Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sun Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceutical Industries Ltd. Major Business
Table 25. Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Product and Services
Table 26. Sun Pharmaceutical Industries Ltd. Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 28. Novartis AG Major Business
Table 29. Novartis AG Small Molecule Injectable Product and Services
Table 30. Novartis AG Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Baxter International Basic Information, Manufacturing Base and Competitors
Table 32. Baxter International Major Business
Table 33. Baxter International Small Molecule Injectable Product and Services
Table 34. Baxter International Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 36. Fresenius Kabi Major Business
Table 37. Fresenius Kabi Small Molecule Injectable Product and Services
Table 38. Fresenius Kabi Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Cipla Ltd Basic Information, Manufacturing Base and Competitors
Table 40. Cipla Ltd Major Business
Table 41. Cipla Ltd Small Molecule Injectable Product and Services
Table 42. Cipla Ltd Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Mylan N.V. Basic Information, Manufacturing Base and Competitors
Table 44. Mylan N.V. Major Business
Table 45. Mylan N.V. Small Molecule Injectable Product and Services
Table 46. Mylan N.V. Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sanofi S.A Basic Information, Manufacturing Base and Competitors
Table 48. Sanofi S.A Major Business
Table 49. Sanofi S.A Small Molecule Injectable Product and Services
Table 50. Sanofi S.A Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Dr. Reddy’s Laboratories Ltd Basic Information, Manufacturing Base and Competitors
Table 52. Dr. Reddy’s Laboratories Ltd Major Business
Table 53. Dr. Reddy’s Laboratories Ltd Small Molecule Injectable Product and Services
Table 54. Dr. Reddy’s Laboratories Ltd Small Molecule Injectable Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Global Small Molecule Injectable Sales by Manufacturer (2019-2021e) & (K Units)
Table 56. Global Small Molecule Injectable Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 57. Market Position of Manufacturers in Small Molecule Injectable, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 58. Global Small Molecule Injectable Production Capacity by Company, (K Units): 2020 VS 2021
Table 59. Head Office and Small Molecule Injectable Production Site of Key Manufacturer
Table 60. Small Molecule Injectable New Entrant and Capacity Expansion Plans
Table 61. Small Molecule Injectable Mergers & Acquisitions in the Past Five Years
Table 62. Global Small Molecule Injectable Sales by Region (2016-2021e) & (K Units)
Table 63. Global Small Molecule Injectable Sales by Region (2021-2026) & (K Units)
Table 64. Global Small Molecule Injectable Revenue by Region (2016-2021e) & (USD Million)
Table 65. Global Small Molecule Injectable Revenue by Region (2021-2026) & (USD Million)
Table 66. Global Small Molecule Injectable Sales by Type (2016-2021e) & (K Units)
Table 67. Global Small Molecule Injectable Sales by Type (2021-2026) & (K Units)
Table 68. Global Small Molecule Injectable Revenue by Type (2016-2021e) & (USD Million)
Table 69. Global Small Molecule Injectable Revenue by Type (2021-2026) & (USD Million)
Table 70. Global Small Molecule Injectable Price by Type (2016-2021e) & (US$/Unit)
Table 71. Global Small Molecule Injectable Price by Type (2021-2026) & (US$/Unit)
Table 72. Global Small Molecule Injectable Sales by Application (2016-2021e) & (K Units)
Table 73. Global Small Molecule Injectable Sales by Application (2021-2026) & (K Units)
Table 74. Global Small Molecule Injectable Revenue by Application (2016-2021e) & (USD Million)
Table 75. Global Small Molecule Injectable Revenue by Application (2021-2026) & (USD Million)
Table 76. Global Small Molecule Injectable Price by Application (2016-2021e) & (US$/Unit)
Table 77. Global Small Molecule Injectable Price by Application (2021-2026) & (US$/Unit)
Table 78. North America Small Molecule Injectable Sales by Country (2016-2021e) & (K Units)
Table 79. North America Small Molecule Injectable Sales by Country (2021-2026) & (K Units)
Table 80. North America Small Molecule Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 81. North America Small Molecule Injectable Revenue by Country (2021-2026) & (USD Million)
Table 82. North America Small Molecule Injectable Sales by Type (2016-2021e) & (K Units)
Table 83. North America Small Molecule Injectable Sales by Type (2021-2026) & (K Units)
Table 84. North America Small Molecule Injectable Sales by Application (2016-2021e) & (K Units)
Table 85. North America Small Molecule Injectable Sales by Application (2021-2026) & (K Units)
Table 86. Europe Small Molecule Injectable Sales by Country (2016-2021e) & (K Units)
Table 87. Europe Small Molecule Injectable Sales by Country (2021-2026) & (K Units)
Table 88. Europe Small Molecule Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 89. Europe Small Molecule Injectable Revenue by Country (2021-2026) & (USD Million)
Table 90. Europe Small Molecule Injectable Sales by Type (2016-2021e) & (K Units)
Table 91. Europe Small Molecule Injectable Sales by Type (2021-2026) & (K Units)
Table 92. Europe Small Molecule Injectable Sales by Application (2016-2021e) & (K Units)
Table 93. Europe Small Molecule Injectable Sales by Application (2021-2026) & (K Units)
Table 94. Asia-Pacific Small Molecule Injectable Sales by Region (2016-2021e) & (K Units)
Table 95. Asia-Pacific Small Molecule Injectable Sales by Region (2021-2026) & (K Units)
Table 96. Asia-Pacific Small Molecule Injectable Revenue by Region (2016-2021e) & (USD Million)
Table 97. Asia-Pacific Small Molecule Injectable Revenue by Region (2021-2026) & (USD Million)
Table 98. Asia-Pacific Small Molecule Injectable Sales by Type (2016-2021e) & (K Units)
Table 99. Asia-Pacific Small Molecule Injectable Sales by Type (2021-2026) & (K Units)
Table 100. Asia-Pacific Small Molecule Injectable Sales by Application (2016-2021e) & (K Units)
Table 101. Asia-Pacific Small Molecule Injectable Sales by Application (2021-2026) & (K Units)
Table 102. South America Small Molecule Injectable Sales by Country (2016-2021e) & (K Units)
Table 103. South America Small Molecule Injectable Sales by Country (2021-2026) & (K Units)
Table 104. South America Small Molecule Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 105. South America Small Molecule Injectable Revenue by Country (2021-2026) & (USD Million)
Table 106. South America Small Molecule Injectable Sales by Type (2016-2021e) & (K Units)
Table 107. South America Small Molecule Injectable Sales by Type (2021-2026) & (K Units)
Table 108. South America Small Molecule Injectable Sales by Application (2016-2021e) & (K Units)
Table 109. South America Small Molecule Injectable Sales by Application (2021-2026) & (K Units)
Table 110. Middle East & Africa Small Molecule Injectable Sales by Country (2016-2021e) & (K Units)
Table 111. Middle East & Africa Small Molecule Injectable Sales by Country (2021-2026) & (K Units)
Table 112. Middle East & Africa Small Molecule Injectable Revenue by Country (2016-2021e) & (USD Million)
Table 113. Middle East & Africa Small Molecule Injectable Revenue by Country (2021-2026) & (USD Million)
Table 114. Middle East & Africa Small Molecule Injectable Sales by Type (2016-2021e) & (K Units)
Table 115. Middle East & Africa Small Molecule Injectable Sales by Type (2021-2026) & (K Units)
Table 116. Middle East & Africa Small Molecule Injectable Sales by Application (2016-2021e) & (K Units)
Table 117. Middle East & Africa Small Molecule Injectable Sales by Application (2021-2026) & (K Units)
Table 118. Direct Channel Pros & Cons
Table 119. Indirect Channel Pros & Cons
Table 120. Small Molecule Injectable Typical Distributors
Table 121. Small Molecule Injectable Typical Customers
List of Figures
Figure 1. Small Molecule Injectable Picture
Figure 2. Global Small Molecule Injectable Sales Market Share by Type in 2020
Figure 3. Intravenous (IV)
Figure 4. Intramuscular (IM)
Figure 5. Subcutaneous (SC)
Figure 6. Global Small Molecule Injectable Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Small Molecule Injectable Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Small Molecule Injectable Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global Small Molecule Injectable Sales (2016-2026) & (K Units)
Figure 13. Global Small Molecule Injectable Price by Type (2016-2026) & (US$/Unit)
Figure 14. Global Small Molecule Injectable Production Capacity (2016-2026) & (K Units)
Figure 15. Global Small Molecule Injectable Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. Small Molecule Injectable Market Drivers
Figure 17. Small Molecule Injectable Market Restraints
Figure 18. Small Molecule Injectable Market Trends
Figure 19. Global Small Molecule Injectable Sales Market Share by Manufacturer in 2020
Figure 20. Global Small Molecule Injectable Revenue Market Share by Manufacturer in 2020
Figure 21. Small Molecule Injectable Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 Small Molecule Injectable Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 Small Molecule Injectable Manufacturer (Revenue) Market Share in 2020
Figure 24. Global Small Molecule Injectable Sales Market Share by Region (2016-2026)
Figure 25. Global Small Molecule Injectable Revenue Market Share by Region (2016-2026)
Figure 26. North America Small Molecule Injectable Revenue (2016-2026) & (USD Million)
Figure 27. Europe Small Molecule Injectable Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific Small Molecule Injectable Revenue (2016-2026) & (USD Million)
Figure 29. South America Small Molecule Injectable Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa Small Molecule Injectable Revenue (2016-2026) & (USD Million)
Figure 31. Global Small Molecule Injectable Sales Market Share by Type (2016-2026)
Figure 32. Global Small Molecule Injectable Revenue Market Share by Type (2016-2026)
Figure 33. Global Small Molecule Injectable Price by Type (2016-2026) & (US$/Unit)
Figure 34. Global Small Molecule Injectable Sales Market Share by Application (2016-2026)
Figure 35. Global Small Molecule Injectable Revenue Market Share by Application (2016-2026)
Figure 36. Global Small Molecule Injectable Price by Application (2016-2026) & (US$/Unit)
Figure 37. North America Small Molecule Injectable Sales Market Share by Type (2016-2026)
Figure 38. North America Small Molecule Injectable Sales Market Share by Application (2016-2026)
Figure 39. North America Small Molecule Injectable Sales Market Share by Country (2016-2026)
Figure 40. North America Small Molecule Injectable Revenue Market Share by Country (2016-2026)
Figure 41. United States Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Small Molecule Injectable Sales Market Share by Type (2016-2026)
Figure 45. Europe Small Molecule Injectable Sales Market Share by Application (2016-2026)
Figure 46. Europe Small Molecule Injectable Sales Market Share by Country (2016-2026)
Figure 47. Europe Small Molecule Injectable Revenue Market Share by Country (2016-2026)
Figure 48. Germany Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Small Molecule Injectable Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Small Molecule Injectable Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Small Molecule Injectable Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Small Molecule Injectable Revenue Market Share by Region (2016-2026)
Figure 57. China Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Small Molecule Injectable Sales Market Share by Type (2016-2026)
Figure 64. South America Small Molecule Injectable Sales Market Share by Application (2016-2026)
Figure 65. South America Small Molecule Injectable Sales Market Share by Country (2016-2026)
Figure 66. South America Small Molecule Injectable Revenue Market Share by Country (2016-2026)
Figure 67. Brazil Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa Small Molecule Injectable Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa Small Molecule Injectable Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Small Molecule Injectable Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Small Molecule Injectable Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa Small Molecule Injectable Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

---